On May 4, Nathaniel Hogrebe, PhD; Matthew Ishahak, PhD; and Jeffrey Millman, PhD had their review titled “Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes,” published in Cell Stem Cell. In diabetes treatment, there is great potential for islet-like endocrine clusters from human pluripotent stem cells (hPSCs) to provide a limitless […]
Hogrebe, Ishahak and Millman review stem cell-derived islet replacement therapy for type 1 diabetes
![](https://endocrinology.wustl.edu/files/2023/08/Untitled-design-93-350x233.png)